Press Releases

All Releases
View Summary Ironwood Pharmaceuticals to Present at the Bank of America Merrill Lynch Healthcare Conference
May 10, 2017
PDF 12.6 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals Presents Data Further Elucidating Linaclotide's Effect on Pain at Digestive Disease Week® 2017
May 9, 2017
PDF 337.2 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals Provides First Quarter 2017 Investor Update
May 8, 2017
PDF 99.1 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals to Present New Data for Linaclotide, Linaclotide Delayed Release and IW-1701 at Digestive Disease Week® 2017
May 1, 2017
PDF 292.1 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals to Host First Quarter 2017 Investor Update Call
Apr 24, 2017
PDF 13.0 KB Add to Briefcase
View Summary Allergan and Ironwood Launch Campaign Designed to Empower the Nearly 64 Million Americans Estimated to Suffer from IBS and CIC to Talk About Bowel Health(1-5)
Apr 13, 2017
PDF 389.5 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals Appoints Dr. Christopher Wright as Senior Vice President of Global Development and Chief Development Officer
Apr 6, 2017
PDF 16.5 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals to Present at Barclays Global Healthcare Conference
Mar 10, 2017
PDF 12.5 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals Showcases Progress Delivering Innovative Medicines to Patients and Building a Top-Performing Commercial Biotech at R&D Day 2017
Mar 9, 2017
PDF 77.4 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals to Present at Cowen and Company 37th Annual Health Care Conference
Feb 28, 2017
PDF 12.6 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals to Host R&D Day on March 9, 2017
Feb 23, 2017
PDF 13.7 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals Provides Fourth Quarter and Full Year 2016 Investor Update
Feb 21, 2017
PDF 144.5 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals to Host Fourth Quarter and Full-Year 2016 Investor Update Call
Feb 7, 2017
PDF 13.0 KB Add to Briefcase
View Summary Astellas and Ironwood Report Positive Top-Line Results from Phase III Linaclotide Trial for Patients with Chronic Constipation Conducted in Japan
Jan 29, 2017
PDF 291.9 KB Add to Briefcase
View Summary U.S. Food and Drug Administration Approves 72 mcg Dose of LINZESS® (linaclotide) for Adults with Chronic Idiopathic Constipation
Jan 26, 2017
PDF 332.0 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals Demonstrates Strong Execution on Strategy to Build Top-Performing Commercial Biotech
Jan 8, 2017
PDF 387.3 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals Appoints Amy Schulman to Board of Directors
Jan 4, 2017
PDF 15.5 KB Add to Briefcase
View Summary Ironwood Announces New Drug Application for DUZALLO™ (Fixed-Dose Combination of Lesinurad and Allopurinol) Has Been Accepted for FDA Review
Jan 4, 2017
PDF 289.6 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals to Present at J.P. Morgan Healthcare Conference
Jan 3, 2017
PDF 12.8 KB Add to Briefcase
View Summary Ironwood and Allergan Report Topline Phase IIb Data Supporting Advancement of Linaclotide Colonic Release-1 (CR1) in IBS-C
Dec 22, 2016
PDF 343.7 KB Add to Briefcase
Showing 1-20 of 235 Page: 1 2 3 4 5 ... 12  Next 20
Add to Briefcase = add release to Briefcase
You are now leaving ironwoodpharma.com. This link will take you to
a website to which our privacy policy does not apply. You are solely
responsible for your interactions with that website.